Ptpn18-KO Mouse
一般名
Ptpn18-KO
製品ID
S-KO-03904
背景情報
C57BL/6JCya
系統ID
KOCMP-19253-Ptpn18-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Ptpn18-KO Mouse（カタログ番号S-KO-03904）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ptpn18-KO
系統ID
KOCMP-19253-Ptpn18-B6J-VA
遺伝子名
製品ID
S-KO-03904
遺伝子別名
FLP-1, FLP1, HSCF, PTP-HSCF, PTP-K1, Ptpk1
遺伝子別名
C57BL/6JCya
遺伝子正式名称
protein tyrosine phosphatase, non-receptor type 18
NCBI ID
修正
Conventional knockout
染色体
Chr 1
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000027302
NCBIトランスクリプトID
NM_011206
ターゲット領域
Exon 6~13
有効領域の大きさ
~4.7 kb
遺伝子研究の概要
Ptpn18, protein tyrosine phosphatase nonreceptor type 18, is a member of the protein tyrosine phosphatases (PTP) family. It has been associated with multiple signaling pathways, such as the PI3K/AKT, MYC-CDK4, and EPOR/JAK2 signaling pathways, and plays important roles in various biological processes related to cell growth, survival, and metastasis [1,2,8]. Genetic models, like gene knockout (KO) mouse models, are valuable tools to study its functions.
In cancer research, Ptpn18 shows diverse roles. In ovarian cancer, knockdown of Ptpn18 inhibited the proliferative and migratory abilities of cancer cells, suppressing ovarian cancer growth in nude mice, indicating its potential as an oncogene in ovarian cancer [1]. In colorectal cancer, Ptpn18 overexpression promoted growth and tumorigenesis, while its deficiency had the opposite effect both in vitro and in vivo, and it activated the MYC-CDK4 axis [2]. In glioblastoma, high expression of Ptpn18 correlated with immune suppression and facilitated tumor progression [3]. In contrast, in breast cancer, Ptpn18 was downregulated in metastatic tissues, and its ectopic expression inhibited breast cancer cell metastasis [4]. In hepatocellular carcinoma, Ptpn18 expression was downregulated, and it exerted inhibitory effects on cell proliferation, migration, and invasion, while promoting apoptosis [5]. In endometrial cancer, silencing of Ptpn18 induced ferroptosis, inhibited proliferation and metastasis, and promoted apoptosis [6,7].
In conclusion, Ptpn18 has context-dependent functions in different biological processes and disease conditions, especially in various cancers. Studies using KO or other loss-of-function models have revealed its complex roles in promoting or inhibiting cancer cell growth, metastasis, and other malignant behaviors, which may provide potential diagnostic and therapeutic targets for related diseases.
References:
1. Mao, Nan, Li, Hu, Yang, Hui, Liang, Zhimin, He, Guansheng. 2022. PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling. In Evidence-based complementary and alternative medicine : eCAM, 2022, 1091042. doi:10.1155/2022/1091042. https://pubmed.ncbi.nlm.nih.gov/35310041/
2. Li, Chao, Li, Shang-Ze, Huang, Xi-Cheng, Song, Xue-Min, Du, Run-Lei. 2020. PTPN18 promotes colorectal cancer progression by regulating the c-MYC-CDK4 axis. In Genes & diseases, 8, 838-848. doi:10.1016/j.gendis.2020.08.001. https://pubmed.ncbi.nlm.nih.gov/34522712/
3. Wang, Tao, Yu, Yang, Ba, Xinlei, Zhao, Yanjiao, Wang, Bing. 2023. PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression. In Oxidative medicine and cellular longevity, 2023, 2994316. doi:10.1155/2023/2994316. https://pubmed.ncbi.nlm.nih.gov/36846716/
4. Wang, Tao, Ba, Xinlei, Zhang, Xiaonan, Yu, Yang, Wang, Bing. 2022. Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2. In Cell death & disease, 13, 720. doi:10.1038/s41419-022-05167-z. https://pubmed.ncbi.nlm.nih.gov/35982039/
5. Zhou, Zhenyu, Yu, Wei, Li, Huoming, Xiao, Zhiyu, Zhang, Jianlong. . Hepatitis B Virus X Protein Represses Expression of Tumor Suppressor PTPN18 in Hepatocellular Carcinoma. In Molecular cancer research : MCR, 22, 891-901. doi:10.1158/1541-7786.MCR-23-0696. https://pubmed.ncbi.nlm.nih.gov/38787319/
6. Wang, Haibo, Peng, Siyuan, Cai, Junhong, Bao, Shan. 2021. Silencing of PTPN18 Induced Ferroptosis in Endometrial Cancer Cells Through p-P38-Mediated GPX4/xCT Down-Regulation. In Cancer management and research, 13, 1757-1765. doi:10.2147/CMAR.S278728. https://pubmed.ncbi.nlm.nih.gov/33642877/
7. Cai, Junhong, Huang, Sizhe, Yi, Yuping, Bao, Shan. 2019. Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer. In Clinical and experimental pharmacology & physiology, 46, 734-742. doi:10.1111/1440-1681.13098. https://pubmed.ncbi.nlm.nih.gov/31034093/
8. Held, Matthew A, Greenfest-Allen, Emily, Su, Su, Stokes, Matthew P, Wojchowski, Don M. 2020. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. In Cellular signalling, 69, 109554. doi:10.1016/j.cellsig.2020.109554. https://pubmed.ncbi.nlm.nih.gov/32027948/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。